ABIVAX Société Anonyme (EPA:ABVX)
113.80
+5.40 (4.98%)
Nov 26, 2025, 10:04 AM CET
ABIVAX Société Anonyme Employees
ABIVAX Société Anonyme had 69 employees as of December 31, 2024. The number of employees increased by 8 or 13.11% compared to the previous year.
Employees
69
Change (1Y)
8
Growth (1Y)
13.11%
Revenue / Employee
€87,290
Profits / Employee
€2,831,710
Market Cap
8.19B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 69 | 8 | 13.11% |
| Dec 31, 2023 | 61 | 37 | 154.17% |
| Dec 31, 2022 | 24 | 0 | - |
| Dec 31, 2021 | 24 | -3 | -11.11% |
| Dec 31, 2020 | 27 | 1 | 3.85% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| EssilorLuxottica Société anonyme | 153,498 |
| emeis Société anonyme | 83,494 |
| Sanofi | 82,878 |
| Eurofins Scientific SE | 62,696 |
| Clariane SE | 61,798 |
| Ramsay Générale de Santé | 40,494 |
| bioMérieux | 14,754 |
| Sartorius Stedim Biotech | 9,901 |
ABIVAX Société Anonyme News
- 5 days ago - Abivax (ABVX) Shares Surge 11% on Takeover Speculation - GuruFocus
- 5 days ago - Abivax gains amid takeover speculation - Seeking Alpha
- 7 days ago - 6 Healthcare Stocks With Strong Upward Momentum - Benzinga
- 17 days ago - Abivax: Phase 3 Data Was A Home Run, Top Target For M&A In 2026 - Seeking Alpha
- 22 days ago - Abivax (ABVX) Reports Promising Phase 3 Trial Results for Ulcerative Colitis Treatment - GuruFocus
- 6 weeks ago - Abivax: Betting Big On The Next Inflammatory Bowel Disease Blockbuster - Seeking Alpha
- 6 weeks ago - Guggenheim Raises Abivax (ABVX) Price Target to $150 with Buy Rating | ABVX Stock News - GuruFocus
- 7 weeks ago - ABIVAX Société Anonyme (ABVX) Shareholder/Analyst Call Transcript - Seeking Alpha